MW EG169 articl NS 20160223171404 captis executive search management consulting leadership board services

Cohbar started at buy with $3 stock price target at Maxim Group

MW EG169 articl NS 20160223171404 captis executive search management consulting leadership board services

Cohbar Inc.

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer’s disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.

This is not a CAPTIS article. Originally, it was published here.